Jun. 13 at 8:40 AM
$PCSA As the insider buying continues in small parts would they be doing it to capture new interests, new money; therefore pull the rug at a later date, likely near after the breast cancer study readout hits the wire with a RS-all, before the mid-year mark? That's per when they expect to have the data for review. Or, is there something else brewing? A new suiter with cash enough to offset previous losses, perhaps with RM in mind would certainly solve liquidity issues, considering the small parts in total now equal sizeable positions per each insider buying. They're also not stupid, therefore I highly doubt they've been setting themselves up for the SEC to climb up their respective asses with a microscope, all due respect, of course.
All things constructive and considered, what's another two-weeks wait and see what the data says? Who knows. Maybe there's a RM in the works? Sure beats dumping and a tax write-off; more or less, either way IMO.
